Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 23;14(3):240-245.
doi: 10.7150/ijms.17738. eCollection 2017.

Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis

Affiliations

Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis

Hitoshi Maruyama et al. Int J Med Sci. .

Abstract

Background: There are only limited data regarding the effect of impaired portal circulation on the glucose metabolism. The study prospectively examined the interrelationship between insulin resistance (IR) and portal haemodynamic abnormality in cirrhosis. Methods: There were 53 cirrhosis patients (61.6 ± 13.0 years) all presenting gastroesophageal varices. Portal haemodynamics by both hepatic venous catheterisation and Doppler ultrasound were examined with respect to the homeostasis model assessment (HOMA)-IR and HOMA2-IR. The IR was defined by HOMA-IR > 3.0 or HOMA2-IR > 2.0. Results: Forty-two patients (79.2%) had collateral vessels, 38 with left gastric vein, 12 with short/posterior gastric vein, 9 with splenorenal shunt, and 3 with inferior mesenteric vein. Multivariate analysis provided significant factors; wedged hepatic venous pressure (HR1.183, 95% CI 1.012-1.383, p=0.035) for HOMA-IR > 3.0, body mass index for HOMA2-IR > 2.0 (HR1.490, 95% CI 1.176-1.888, p=0.001), and collateral flow volume for both HOMA-IR > 3.0 (HR1.007, 95% CI 1.001-1.014, p=0.015) and HOMA2-IR > 2.0 (HR 1.007, 95% CI 1.002-1.013, p=0.009). The best cut-off value of collateral flow volume was 165 ml/min for detecting the HOMA-IR > 3.0 showing area under the receiver operating characteristic curve (AUROC) 0.688 (Odds ratio, 5.33) with sensitivity 70% and specificity 69.6%, and was 165 ml/min for detecting median value of HOMA2-IR > 2.0 showing AUROC 0.698 (odds ratio, 5.7) with sensitivity 75% and specificity 65.5%. Conclusion: There is a close linkage between the IR and impaired portal haemodynamics presented by the collateral development, suggesting the underlying pathogenesis of portal hypertension in cirrhosis patients.

Keywords: Insulin resistance; cirrhosis; diabetes; portal hemodynamics.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Figure 1
Figure 1
The best cut-off value of collateral flow volume was 165 ml/min for a detection of HOMA-IR 3.0 showing AUROC 0.688 (Odds ratio, 5.33) with sensitivity 70% and specificity 69.6%. AUROC, area under the receiver operating characteristic curve; HOMA, homeostasis model assessment; IR, insulin resistance
Figure 2
Figure 2
The best cut-off value of collateral flow volume was 165 ml/min for a detection of HOMA2-IR 2.0 showing AUROC 0.698 (Odds ratio, 5.7) with sensitivity 75% and specificity 65.5%. AUROC, area under the receiver operating characteristic curve; HOMA, homeostasis model assessment; IR, insulin resistance

Similar articles

Cited by

References

    1. Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749–1761. - PubMed
    1. Durand F, Valla D. Assessment of prognosis of cirrhosis. Semin Liver Dis. 2008;28:110–122. - PubMed
    1. Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology. 2008;134:1682–1698. - PubMed
    1. CDC. Viral hepatitis surveillance, United States 2010 National Center for HIV SaTPDoHASB. Atlanta, GA: Centers for Disease Control and Prevention; 2010.
    1. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156:271–278. - PubMed

MeSH terms